Substance / Medication

Fosfestrol

Overview

Active Ingredient
fosfestrol
RxNorm CUI
25284

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis.
Carletti Filippo, Maggi Martina, Fazekas Tamas et al. · Eur Radiol · 2026
PMID: 40307530Meta-AnalysisFull text (PMC)
Chinese medicines as therapeutic options for treating prostate cancer: Therapeutic effects and underlying mechanisms.
Li Shenglong, Jing Shuaishuai, Zhou Jiuyun et al. · J Ethnopharmacol · 2026
PMID: 40882785Meta-Analysis
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer.
Orlando M, Chacón M, Salum G et al. · Ann Oncol · 2000
PMID: 10761752Observational
Outcomes and toxicity of oral Fosfestrol in metastatic castration-resistant prostate cancer-a real-world experience.
Nandini Devi R, Praveen Kumar Shenoy V P, Ismail Irshad et al. · Ecancermedicalscience · 2023
PMID: 37799959OtherFull text (PMC)
Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization.
Galatage Sunil T, Manjappa Arehalli S, Bhagwat Durgacharan A et al. · Eur J Pharm Biopharm · 2023
PMID: 37858803Other
Assay of the synthetic estrogen fosfestrol in pharmaceutical formulations using capillary electrophoresis.
G Themelis Demetrius, Trellopoulos Anastasios V, Tzanavaras Paraskevas D et al. · J Pharm Biomed Anal · 2005
PMID: 15953702Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fosfestrol (substance)
SNOMED CT
395979004
UMLS CUI
C0060692
RxNorm CUI
25284

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.